The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
... background articles here:
https://www.labmate-online.com/news/news-and-views/5/avacta-group/gene-therapies-to-incorporate-enhanced-immune-modulatory-effects/51469
Just some light reading for those looking at the breadth of Avacta activity.
Onwards Avacta.
DTW,
Here's an idea of the TAM:
https://www.biospace.com/article/cancer-therapeutics-market-size-to-reach-us-335-06-bn-by-2029/
Onwards Avacta.
The Beaston looking for volunteers for a different cancer type seems to indicate progress and the "theoretical possibility" that data could be made available to "interested parties" seems to indicate that there are interested parties.
Thank you.
Onwards Avacta.
Oh and a UT the other way was amazing.
I thought I had said partnering:
https://avacta.com/diagnostics/partnering/
Not sure where "new products" has sprung from as my belief is that we provide the affimers that other companies want.
Onwards Avacta.
Bella,
I think we are likely to see more on the partnering front with this registration as well:
https://avacta.com/diagnostics/partnering/
Onwards Avacta.
.... been on a boozy lunch or are they filling a buy order?
Time will tell.
Meanwhile, a horse called FOMO is running in The 415 at Beverley.
Other (undeclared) runners include:
DOSE ESCALATION
THIRD COHORT
SAFETY COMMITEE
LATERAL FLOW
RELAUNCH
PETI FAP
IMAGING
SLIDE FOURTEEN
MILESTONE PAYMENT
Onwards Avacta.